RecruitingNot ApplicableNCT03978078

A Clinicobiological Database in Metastatic Digestive Cancers

Development of a Prospective Clinicobiological Database in Metastatic Digestive Cancers


Sponsor

Institut du Cancer de Montpellier - Val d'Aurelle

Enrollment

200 participants

Start Date

Sep 12, 2016

Study Type

INTERVENTIONAL

Conditions

Summary

Creation of a collection of blood samples that will be collected before and then under treatment in patients with digestive adenocarcinoma during the 1st and 2nd metastatic line and which, depending on scientific progress, can be used for research projects aimed at developing tailored patient management strategies.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study creates a database of clinical and biological information from patients with metastatic digestive cancers (including colon, rectal, small intestine, pancreatic, stomach, bile duct, and esophageal cancers). The data will be used to understand how these cancers behave and respond to treatment. **You may be eligible if...** - You are 18 or older - You have confirmed adenocarcinoma (a common cancer type) of the colon, rectum, small intestine, pancreas, stomach, bile duct, or esophagus that has spread (metastatic) - You are about to start your first or second line of chemotherapy or targeted therapy for metastatic disease - You have signed an informed consent form **You may NOT be eligible if...** - You are pregnant or breastfeeding - You have already started treatment for metastatic disease - You are enrolled in a Phase I or II clinical trial that modifies standard treatment - You are not affiliated with a social security system (in France) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERBiological collection

\- Blood samples collected at different times : Before treatment, during treatment (approximately every other month) through the end of treatment


Locations(1)

Institut régional du cancer de Montpellier

Montpellier, Hérault, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03978078


Related Trials